These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23178377)

  • 1. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
    Welschinger R; Liedtke F; Basnett J; Dela Pena A; Juarez JG; Bradstock KF; Bendall LJ
    Exp Hematol; 2013 Mar; 41(3):293-302.e1. PubMed ID: 23178377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
    Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
    Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside-polyarginine conjugates.
    Berchanski A; Kalinkovich A; Ludin A; Lapidot T; Lapidot A
    FEBS J; 2011 Nov; 278(21):4150-65. PubMed ID: 21910828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro.
    Martin C; Bridger GJ; Rankin SM
    Br J Haematol; 2006 Aug; 134(3):326-9. PubMed ID: 16787495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
    Pusic I; DiPersio JF
    Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
    De Clercq E
    Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells.
    Wuchter P; Leinweber C; Saffrich R; Hanke M; Eckstein V; Ho AD; Grunze M; Rosenhahn A
    Cell Tissue Res; 2014 Feb; 355(2):315-26. PubMed ID: 24337688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study.
    McNulty MA; Virdi AS; Christopherson KW; Sena K; Frank RR; Sumner DR
    Clin Orthop Relat Res; 2012 Sep; 470(9):2503-12. PubMed ID: 22528386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model.
    Shin JW; Lee JK; Lee JE; Min WK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2011 Jul; 29(7):1075-89. PubMed ID: 21608078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Caocci G; Ledda A; Floris R; Vacca A; Arras M; Greco M; Sanna M; La Nasa G
    Leuk Lymphoma; 2014 Feb; 55(2):462-3. PubMed ID: 23713454
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
    Juarez J; Bradstock KF; Gottlieb DJ; Bendall LJ
    Leukemia; 2003 Jul; 17(7):1294-300. PubMed ID: 12835717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.
    Bonig H; Chudziak D; Priestley G; Papayannopoulou T
    Exp Hematol; 2009 Mar; 37(3):402-15.e1. PubMed ID: 19157683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mobilization of subsets of progenitor cells from the bone marrow.
    Pitchford SC; Furze RC; Jones CP; Wengner AM; Rankin SM
    Cell Stem Cell; 2009 Jan; 4(1):62-72. PubMed ID: 19128793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
    Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
    Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis.
    Zhang J; Ren X; Shi W; Wang S; Chen H; Zhang B; Wang Z; Zhou Y; Chen L; Zhang R; Lv Y; Zhou J; Nan X; He L; Yue W; Li Y; Pei X
    Blood; 2014 Jan; 123(3):428-41. PubMed ID: 24196072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
    Hess DA; Bonde J; Craft TP; Wirthlin L; Hohm S; Lahey R; Todt LM; Dipersio JF; Devine SM; Nolta JA
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):398-411. PubMed ID: 17382247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.